Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6

Q3 Biochemistry, Genetics and Molecular Biology
Lalitha Venkatramani, Eric S Johnson, Gundurao Kolavi, Gillian M Air, Wayne J Brouillette, Blaine HM Mooers
{"title":"Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6","authors":"Lalitha Venkatramani,&nbsp;Eric S Johnson,&nbsp;Gundurao Kolavi,&nbsp;Gillian M Air,&nbsp;Wayne J Brouillette,&nbsp;Blaine HM Mooers","doi":"10.1186/1472-6807-12-7","DOIUrl":null,"url":null,"abstract":"<p>Influenza neuraminidase (NA) is an important target for antiviral inhibitors since its active site is highly conserved such that inhibitors can be cross-reactive against multiple types and subtypes of influenza. Here, we discuss the crystal structure of neuraminidase subtype N9 complexed with a new benzoic acid based inhibitor (<b>2</b>) that was designed to add contacts by overpacking one side of the active site pocket. Inhibitor <b>2</b> uses benzoic acid to mimic the pyranose ring, a bis-(hydroxymethyl)-substituted 2-pyrrolidinone ring in place of the <i>N</i>-acetyl group of the sialic acid, and a branched aliphatic structure to fill the sialic acid C6 subsite.</p><p>Inhibitor <b>2</b> {4-[2,2-bis(hydroxymethyl)-5-oxo-pyrrolidin-1-yl]-3-[(dipropylamino)methyl)]benzoic acid} was soaked into crystals of neuraminidase of A/tern/Australia/G70c/75 (N9), and the structure refined with 1.55?? X-ray data. The benzene ring of the inhibitor tilted 8.9° compared to the previous compound (<b>1)</b>, and the number of contacts, including hydrogen bonds, increased. However, the IC<sub>50</sub> for compound <b>2</b> remained in the low micromolar range, likely because one propyl group was disordered. In this high-resolution structure of NA isolated from virus grown in chicken eggs, we found electron density for additional sugar units on the N-linked glycans compared to previous neuraminidase structures. In particular, seven mannoses and two N-acetylglucosamines are visible in the glycan attached to Asn200. This long, branched high-mannose glycan makes significant contacts with the neighboring subunit.</p><p>We designed inhibitor <b>2</b> with an extended substituent at C4-corresponding to C6 of sialic acid-to increase the contact surface in the C6-subsite and to force the benzene ring to tilt to maximize these interactions while retaining the interactions of the carboxylate and the pyrolidinone substituents. The crystal structure at 1.55?? showed that we partially succeeded in that the ring in <b>2</b> is tilted relative to <b>1</b> and the number of contacts increased, but one hydrophobic branch makes no contacts, perhaps explaining why the IC<sub>50</sub> did not decrease. Future design efforts will include branches of unequal length so that both branches may be accommodated in the C6-subsite without conformational disorder. The high-mannose glycan attached to Asn200 makes several inter-subunit contacts and appears to stabilize the tetramer.</p>","PeriodicalId":51240,"journal":{"name":"BMC Structural Biology","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2012-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1472-6807-12-7","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Structural Biology","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/1472-6807-12-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 13

Abstract

Influenza neuraminidase (NA) is an important target for antiviral inhibitors since its active site is highly conserved such that inhibitors can be cross-reactive against multiple types and subtypes of influenza. Here, we discuss the crystal structure of neuraminidase subtype N9 complexed with a new benzoic acid based inhibitor (2) that was designed to add contacts by overpacking one side of the active site pocket. Inhibitor 2 uses benzoic acid to mimic the pyranose ring, a bis-(hydroxymethyl)-substituted 2-pyrrolidinone ring in place of the N-acetyl group of the sialic acid, and a branched aliphatic structure to fill the sialic acid C6 subsite.

Inhibitor 2 {4-[2,2-bis(hydroxymethyl)-5-oxo-pyrrolidin-1-yl]-3-[(dipropylamino)methyl)]benzoic acid} was soaked into crystals of neuraminidase of A/tern/Australia/G70c/75 (N9), and the structure refined with 1.55?? X-ray data. The benzene ring of the inhibitor tilted 8.9° compared to the previous compound (1), and the number of contacts, including hydrogen bonds, increased. However, the IC50 for compound 2 remained in the low micromolar range, likely because one propyl group was disordered. In this high-resolution structure of NA isolated from virus grown in chicken eggs, we found electron density for additional sugar units on the N-linked glycans compared to previous neuraminidase structures. In particular, seven mannoses and two N-acetylglucosamines are visible in the glycan attached to Asn200. This long, branched high-mannose glycan makes significant contacts with the neighboring subunit.

We designed inhibitor 2 with an extended substituent at C4-corresponding to C6 of sialic acid-to increase the contact surface in the C6-subsite and to force the benzene ring to tilt to maximize these interactions while retaining the interactions of the carboxylate and the pyrolidinone substituents. The crystal structure at 1.55?? showed that we partially succeeded in that the ring in 2 is tilted relative to 1 and the number of contacts increased, but one hydrophobic branch makes no contacts, perhaps explaining why the IC50 did not decrease. Future design efforts will include branches of unequal length so that both branches may be accommodated in the C6-subsite without conformational disorder. The high-mannose glycan attached to Asn200 makes several inter-subunit contacts and appears to stabilize the tetramer.

Abstract Image

一种新型流感神经氨酸酶苯甲酸抑制剂的晶体结构与C6亚位过度堆积诱导的新倾斜结合
流感神经氨酸酶(NA)是抗病毒抑制剂的重要靶点,因为它的活性位点是高度保守的,因此抑制剂可以对多种类型和亚型流感产生交叉反应。在这里,我们讨论了神经氨酸酶亚型N9与一种新的苯甲酸基抑制剂(2)络合的晶体结构,该抑制剂被设计为通过在活性位点口袋的一侧过度填充来增加接触。抑制剂2用苯甲酸模拟吡喃糖环,用双(羟甲基)取代的2-吡咯烷酮环代替唾液酸的n -乙酰基,用支链脂肪族结构填充唾液酸C6亚位。将抑制剂2{4-[2,2-二(羟甲基)-5-氧吡咯烷-1-基]-3-[(二丙胺)甲基)]苯甲酸}浸泡在A/tern/Australia/G70c/75 (N9)的神经氨酸酶晶体中,以1.55??x射线数据。与前一种化合物(1)相比,抑制剂的苯环倾斜8.9°,包括氢键在内的接触数增加。然而,化合物2的IC50仍然保持在低微摩尔范围内,可能是因为一个丙基无序。在这个从鸡蛋中培养的病毒中分离的NA的高分辨率结构中,我们发现了与以前的神经氨酸酶结构相比,n链聚糖上额外糖单元的电子密度。特别是,在Asn200上的聚糖中可以看到7个甘露糖和2个n -乙酰氨基葡萄糖。这种长而支的高甘露糖聚糖与邻近的亚基有重要的接触。我们设计的抑制剂2在c4 -对应于唾液酸的C6-上有一个扩展取代基,以增加C6亚位的接触面,并迫使苯环倾斜以最大化这些相互作用,同时保留羧酸盐和邻苯二酮取代基的相互作用。1.55时的晶体结构?表明,我们部分成功地使2中的环相对于1倾斜,接触数量增加,但一个疏水分支没有接触,这可能解释了为什么IC50没有下降。未来的设计工作将包括长度不等的分支,以便两个分支都可以容纳在c6亚位点中,而不会出现构象紊乱。附着在Asn200上的高甘露糖聚糖在亚基间产生了几个接触,似乎稳定了四聚体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: BMC Structural Biology is an open access, peer-reviewed journal that considers articles on investigations into the structure of biological macromolecules, including solving structures, structural and functional analyses, and computational modeling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信